Reproducibility and clinical potential of myocardial mass at risk calculated by a novel software utilizing cardiac computed tomography information

Satoru Sumitsuji, Seiko Ide, Patrick T. Siegrist, Youssef Salah, Kensuke Yokoi, Masatoki Yoshida, Masaki Awata, Keita Yamasaki, Kouichi Tachibana, Hideaki Kaneda, Shinsuke Nanto, Yasushi Sakata

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


To select the best revascularization strategy a correct understanding of the ischemic territory and the coronary anatomy is crucial. Stress myocardial perfusion single photon emission computed tomography (SPECT) is the gold standard to assess ischemia, however, SPECT has important limitations such as lack of coronary anatomical information or false negative results due to balanced ischemia in multi-vessel disease. Angiographic scores are based on anatomical characteristics of coronary arteries but they lack information on the extent of jeopardized myocardium. Cardiac computed tomography (CCT) has the ability to evaluate the coronary anatomy and myocardium in one sequence, which is theoretically the ideal method to assess the myocardial mass at risk (MMAR) for any target lesion located at any point in the coronary tree. In this study we analyzed MMAR of the three main coronary arteries and three major side branches; diagonal (Dx), obtuse marginal (OM), and posterior descending artery (PDA) in 42 patients with normal coronary arteries using an algorithm based on the Voronoi method. The distribution of MMAR among the three main coronary arteries was 44.3 ± 5.6 % for the left anterior descending artery, 28.2 ± 7.3 % for the left circumflex artery, and 26.8 ± 8.6 % for the right coronary artery. MMAR of the three major side branches was 11.3 ± 3.9 % for the Dx, 12.6 ± 5.2 % for the OM and 10.2 ± 3.4 % for the PDA. Intra- and inter-observer analysis showed excellent correlation (r = 0.97; p < 0.0001 and r = 0.95; p < 0.0001, respectively). In conclusion, CCT-based MMAR assessment is reliable and may offer important information for selection of the optimal revascularization procedure.

Original languageEnglish
Pages (from-to)218-225
Number of pages8
JournalCardiovascular Intervention and Therapeutics
Issue number3
Publication statusPublished - Jul 1 2016


  • Cardiac computed tomography
  • Myocardial mass at risk
  • Voronoi method

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Reproducibility and clinical potential of myocardial mass at risk calculated by a novel software utilizing cardiac computed tomography information'. Together they form a unique fingerprint.

Cite this